UnitedHealth Stock (UNH) Slips as DOJ Broadens Criminal Probe
UnitedHealth (UNH), the largest U.S. health insurer, faced renewed pressure as the Department of Justice expanded its criminal investigation beyond Medicare Advantage billing to include other business practices. The probe now scrutinizes Optum Rx's prescription management and doctor reimbursements, adding layers of regulatory risk. Shares closed down 1.4% at $300.43.
Concurrently, the company battles a civil fraud investigation into Medicare operations and an FTC lawsuit alleging insulin price inflation by OptumRx and other pharmacy benefit managers. UnitedHealth denies all allegations, labeling them "baseless." These legal headwinds compound existing turbulence for the healthcare giant.